
Women may soon have a vaccine they can take during a pregnancy to help protect their newborn from respiratory syncytial virus (RSV), following U.S. Food and Drug Administration approval of the shot, called Abrysvo, on Monday The vaccine is designed to be given to pregnant women between 32 and 36 weeks of pregnancy as a… read on > read on >